Glucocorticoid Therapy and the Risk of Infection in Patients With Newly Diagnosed Autoimmune Disease

Glucocorticoid (GC) therapy is associated with the risk of life-threatening adverse events in patients with autoimmune disease. To determine accurately the incidence and predictors of GC-related adverse events during initial GC treatment, we conducted a cohort study. Patients with autoimmune disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Migita, Kiyoshi, Sasaki, Yasuharu, Ishizuka, Naoki, Arai, Toru, Kiyokawa, Tetsuyuki, Suematsu, Eiichi, Yoshimura, Mitsuhiro, Kawabe, Yojiro, Matsumura, Ryutaro, Akagawa, Shinobu, Mori, Shunsuke, Shirai, Masahiro, Watanabe, Yukio, Minami, Naoya, Soga, Takayoshi, Owan, Isoko, Ohshima, Shiro, Yoshizawa, Shigeru, Matsui, Toshihiro, Tohma, Shigeto, Bito, Seiji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2013
Materias:
Original Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4553976/
https://www.ncbi.nlm.nih.gov/pubmed/23982055
http://dx.doi.org/10.1097/MD.0b013e3182a72299

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4553976/
https://www.ncbi.nlm.nih.gov/pubmed/23982055
http://dx.doi.org/10.1097/MD.0b013e3182a72299

Ejemplares similares